EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Bovine milk‐derived extracellular vesicles enhance doxorubicin sensitivity in triple negative breast cancer cells by targeting metabolism and STAT signalling

Rahul Sanwlani, Taeyoung Kang, Sriram Gummadi, Christina Nedeva, Ching-Seng Ang, Suresh Mathivanan iD

PROTEOMICS · 2023-09 · 23 (18)

DOI: 10.1002/pmic.202200482 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PROTEOMICS, online erschienen am 27.06.2023. Verfasst von Rahul Sanwlani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Extracellular Vesicles. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metastatic triple‐negative breast cancer (TNBC) has a low 5‐year survival rate of below 30% with systemic chemotherapy being the most widely used treatment. Bovine milk‐derived extracellular vesicles (MEVs) have been previously demonstrated to have anti‐cancer attributes. In this study, we isolated bovine MEVs from commercial milk and characterised them according to MISEV guidelines. Bovine MEVs sensitised TNBC cells to doxorubicin, resulting in reduced metabolic potential and cell‐viability. Label‐free quantitative proteomics of cells treated with MEVs and/or doxorubicin suggested that combinatorial treatment depleted various pro‐tumorigenic interferon‐inducible gene products and proteins with metabolic function, previously identified as therapeutic targets in TNBC. Combinatorial treatment also led to reduced abundance of various STAT proteins and their downstream oncogenic targets with roles in cell‐cycle and apoptosis. Taken together, this study highlights the ability of bovine MEVs to sensitise TNBC cells to standard‐of‐care therapeutic drug doxorubicin, paving the way for novel treatment regimens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsExtracellular VesiclesHumansAnimalsMilkCell Line, TumorDoxorubicin

Stichwörter der Autor:innen

bovine milk-derived extracellular vesiclescancer chemotherapydietary extracellular vesiclesspecies crosstalkstat signallingtriple-negative breast cancer

Substanzen

Doxorubicin

Autor:innen und Institutionen

  • Department of Biochemistry, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria, Australia.
  • The Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia.

ORCID-Profile: Suresh Mathivanan

Zitieren

APA

Sanwlani, R., Kang, T., Gummadi, S., Nedeva, C., Ang, C. S., & Mathivanan, S. (2023). Bovine milk‐derived extracellular vesicles enhance doxorubicin sensitivity in triple negative breast cancer cells by targeting metabolism and STAT signalling. PROTEOMICS, 23(18). https://doi.org/10.1002/pmic.202200482

Vancouver

Sanwlani R, Kang T, Gummadi S, Nedeva C, Ang CS, Mathivanan S. Bovine milk‐derived extracellular vesicles enhance doxorubicin sensitivity in triple negative breast cancer cells by targeting metabolism and STAT signalling. PROTEOMICS. 2023;23(18). doi:10.1002/pmic.202200482

BibTeX
@article{Sanwlani2023,
  author = {Sanwlani, Rahul and Kang, Taeyoung and Gummadi, Sriram and Nedeva, Christina and Ang, Ching-Seng and Mathivanan, Suresh},
  title = {Bovine milk‐derived extracellular vesicles enhance doxorubicin sensitivity in triple negative breast cancer cells by targeting metabolism and STAT signalling},
  journal = {PROTEOMICS},
  year = {2023},
  volume = {23},
  number = {18},
  doi = {10.1002/pmic.202200482}
}
Kostenlos starten →